Finance

Lists
PMVP:NASDAQ
PMV Pharmaceuticals Inc
၁.၇၉ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၅, GMT-၄ ၁၅:၄၄:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMVP...
Open
၁.၈၀ US$
High
၁.၈၄ US$
Low
၁.၇၀ US$
Mkt. cap
၁၃.၅၂ ကုဋေ
Avg. vol.
၉.၇၆ သိန်း
Volume
၇.၅၉ သိန်း
52-wk high
၁.၉၁ US$
52-wk low
၁.၀၂ US$
EPS
-၁.၄၁ US$
Beta
၁.၃၆
Shares outstanding
၇.၅၅ ကုဋေ
No. of employees
၅၄
Open
၁.၈၀ US$
High
၁.၈၄ US$
Low
၁.၇၀ US$
Mkt. cap
၁၃.၅၂ ကုဋေ
Avg. vol.
၉.၇၆ သိန်း
Volume
၇.၅၉ သိန်း
52-wk high
၁.၉၁ US$
52-wk low
၁.၀၂ US$
EPS
-၁.၄၁ US$
Beta
၁.၃၆
Shares outstanding
၇.၅၅ ကုဋေ
No. of employees
၅၄
News stories
From web sources and news partners
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၆ နာရီ
PMV Pharmaceuticals Adds Veteran Investor to Board
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၇ နာရီ
A Q1 2027 application for accelerated approval is planned for PMV’s ovarian cancer drug.
About PMV Pharmaceuticals Inc
CEO-
Employees၅၄
Founded၂၀၁၃
Headquarters-
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to PMVP in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PMVP in the last 3 months.
Highest
Current ၁.၇၉ US$
၅.၀၀ US$ (+၁၇၉.၃၃%)
Average
၄.၂၀ US$ (+၁၃၄.၆၄%)
Lowest
၃.၀၀ US$ (+၆၇.၆၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
၅.၀၀ US$
+၁၇၉.၃%
09/08/2026
Unknown Analyst
Craig-Hallum
Buy
Reiterated
၄.၀၀ US$
+၁၂၃.၅%
09/01/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
၄.၀၀ US$
+၁၂၃.၅%
09/01/2026
Jay Olson
Oppenheimer
Buy
Reiterated
၅.၀၀ US$
+၁၇၉.၃%
09/01/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
၅.၀၀ US$
+၁၇၉.၃%
09/01/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
၃.၀၀ US$
+၆၇.၆%
08/17/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Reiterated
၃.၀၀ US$
+၆၇.၆%
08/17/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/12/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
၄.၀၀ US$
+၁၂၃.၅%
11/13/2025
Last report
၂၀၂၆ ဩ ၁၄
Fiscal period
Q2 2026
EPS / Est. (USD)
-၀.၃၄ US$ / -၀.၄၀ US$
+၁၅.၀၀%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၈၂ ကုဋေ
၁.၅၈ ကုဋေ
၁.၅၃ ကုဋေ
၁.၄၇ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၃၁ သန်း
၃.၄၂ သန်း
၃.၆၉ သန်း
၄.၂၀ သန်း
Operating expense
၂.၂၅ ကုဋေ
၁.၉၂ ကုဋေ
၁.၉၀ ကုဋေ
၁.၈၉ ကုဋေ
Total operating expenses
၂.၂၅ ကုဋေ
၁.၉၂ ကုဋေ
၁.၉၀ ကုဋေ
၁.၈၉ ကုဋေ
Operating income
-၂.၂၅ ကုဋေ
-၁.၉၂ ကုဋေ
-၁.၉၀ ကုဋေ
-၁.၈၉ ကုဋေ
Other non operating income
-၂.၃၀ သောင်း
-၁.၀၀ ထောင်
၁.၀၀ ထောင်
၁.၀၀ သောင်း
EBT including unusual items
-၂.၁၁ ကုဋေ
-၁.၈၀ ကုဋေ
-၁.၈၀ ကုဋေ
-၁.၈၁ ကုဋေ
EBT excluding unusual items
-၂.၁၁ ကုဋေ
-၁.၈၀ ကုဋေ
-၁.၈၀ ကုဋေ
-၁.၈၁ ကုဋေ
Income tax expense
-၆.၀၀ ထောင်
၂.၆၀ သောင်း
-
၃.၀၀ ထောင်
Effective tax rate
၀.၀၃%
-၀.၁၄%
-
-၀.၀၂%
Other operating expenses
-
-
-
-
Net income
-၂.၁၁ ကုဋေ
-၁.၈၀ ကုဋေ
-၁.၈၀ ကုဋေ
-၁.၈၁ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၄၀
-၀.၃၄
-၀.၃၄
-၀.၃၄
Interest and investment income
၁.၄၈ သန်း
၁.၂၃ သန်း
၉.၈၀ သိန်း
၇.၈၈ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၄၈ သန်း
၁.၂၃ သန်း
၉.၈၀ သိန်း
၇.၈၈ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၂.၂၅ ကုဋေ
-၁.၉၂ ကုဋေ
-၁.၉၀ ကုဋေ
-၁.၈၉ ကုဋေ
Gain or loss from assets sale
-၁.၀၀ ထောင်
-
-
၂.၅၀ သောင်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ